Cargando…

Inactivated Whole Virus Influenza A (H5N1) Vaccine

Detalles Bibliográficos
Autores principales:	Vajo, Zoltan, Kosa, Lajos, Visontay, Ildiko, Jankovics, Mate, Jankovics, Istvan
Formato:	Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2007
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738456/ https://www.ncbi.nlm.nih.gov/pubmed/18044056 http://dx.doi.org/10.3201/eid1305.061248

Ejemplares similares

Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval – a useful approach to pandemic vaccine development even in less well developed countries?
por: Vajo, Zoltan, et al.
Publicado: (2008)

Protection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination
por: Sarkadi, Julia, et al.
Publicado: (2013)

A Reduced Dose Whole Virion Aluminum Adjuvanted Seasonal Influenza Vaccine Is Immunogenic, Safe, and Well Tolerated in Pediatric Patients †
por: Vajo, Zoltan, et al.
Publicado: (2021)

Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy
por: Leibinger, Evelin A., et al.
Publicado: (2021)

Characterization of a whole, inactivated influenza (H5N1) vaccine
por: Tada, Yoshikazu
Publicado: (2008)

Extinction of the Influenza B Yamagata Line during the COVID Pandemic—Implications for Vaccine Composition
por: Vajo, Zoltan, et al.
Publicado: (2022)

A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice
por: Hovden, Arnt‐Ove, et al.
Publicado: (2009)

Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures
por: Geeraedts, Felix, et al.
Publicado: (2010)

Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling
por: Geeraedts, Felix, et al.
Publicado: (2008)

Developing Immunity Testing for SARS-CoV-2 and Other Novel Vaccines—Correlates of Immunogenicity Parameters with Protection
por: Vajo, Zoltan
Publicado: (2022)

Effects of the combination of a monoclonal agonistic mouse anti-OX40 antibody and toll-like receptor agonists: Unmethylated CpG and LPS on an MB49 bladder cancer cell line in a mouse model
por: Gulyás, Dominik, et al.
Publicado: (2022)

Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus
por: Hatta, Masato, et al.
Publicado: (2018)

Induction of Influenza (H5N8) Antibodies by Modified Vaccinia Virus Ankara H5N1 Vaccine
por: de Vries, Rory D., et al.
Publicado: (2015)

Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
por: Zhang, Zhegang, et al.
Publicado: (2022)

Protective efficacy of an inactivated vaccine against H9N2 avian influenza virus in ducks
por: Teng, Qiaoyang, et al.
Publicado: (2015)

Assessing the efficacy of a recombinant H9N2 avian influenza virus–inactivated vaccine
por: Song, Cai Liang, et al.
Publicado: (2020)

A Mechanistic Study on the Destabilization of Whole Inactivated Influenza Virus Vaccine in Gastric Environment
por: Choi, Hyo-Jick, et al.
Publicado: (2013)

Vaccination with an inactivated canine influenza H3N2 virus vaccine is safe and elicits an immune response in cats
por: Velineni, Sridhar, et al.
Publicado: (2019)

Extreme thermal stability of the antiGFP nanobody – GFP complex
por: Kakasi, Balázs, et al.
Publicado: (2023)

In Vivo Immunostaining of Hemocyte Compartments in Drosophila for Live Imaging
por: Csordás, Gábor, et al.
Publicado: (2014)

Swine Influenza A Vaccines, Pandemic (H1N1) 2009 Virus, and Cross-Reactivity
por: Dürrwald, Ralf, et al.
Publicado: (2010)

Development of an Inactivated Avian Influenza Virus Vaccine against Circulating H9N2 in Chickens and Ducks
por: Liu, Yuzhuo, et al.
Publicado: (2023)

Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses
por: Allen, James D., et al.
Publicado: (2018)

Protection against H5N1 Highly Pathogenic Avian and Pandemic (H1N1) 2009 Influenza Virus Infection in Cynomolgus Monkeys by an Inactivated H5N1 Whole Particle Vaccine
por: Nakayama, Misako, et al.
Publicado: (2013)

Asymptomatic and Mild SARS-CoV-2 Infections in a Hungarian Outpatient Cohort in the First Year of the COVID-19 Pandemic
por: Jankovics, István, et al.
Publicado: (2023)

Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients
por: Lagler, H, et al.
Publicado: (2010)

Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration
por: Budimir, Natalija, et al.
Publicado: (2013)

Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques
por: Chua, Brendon Y., et al.
Publicado: (2022)

Correction: Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses
por: Allen, James D., et al.
Publicado: (2018)

Post-exposure treatment with whole inactivated H5N1 avian influenza virus protects against lethal homologous virus infection in mice
por: Hagan, Mable, et al.
Publicado: (2016)

Induction of immune response in chickens primed in ovo with an inactivated H9N2 avian influenza virus vaccine
por: Astill, Jake, et al.
Publicado: (2018)

Evaluation of a Subunit H5 Vaccine and an Inactivated H5N2 Avian Influenza Marker Vaccine in Ducks Challenged with Vietnamese H5N1 Highly Pathogenic Avian Influenza Virus
por: Chua, Tze-Hoong, et al.
Publicado: (2010)

Chlorine Inactivation of Highly Pathogenic Avian Influenza Virus (H5N1)
por: Rice, Eugene W., et al.
Publicado: (2007)

Avian Influenza Virus (H5N1) Mortality Surveillance
por: Komar, Nicholas, et al.
Publicado: (2008)

Avian Influenza Virus (H5N1) in Human, Laos
por: Puthavathana, Pilaipan, et al.
Publicado: (2009)

Contaminated Soil and Transmission of Influenza Virus (H5N1)
por: Gutiérrez, Ramona A., et al.
Publicado: (2012)

Enhanced Recombinant Protein Production of Soluble, Highly Active and Immobilizable PNGase F
por: Kovács, Noémi, et al.
Publicado: (2022)

Enhanced Immunogenicity of a Whole-Inactivated Influenza A Virus Vaccine Using Optimised Irradiation Conditions
por: Singleton, Eve Victoria, et al.
Publicado: (2021)

Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs
por: Geeraedts, Felix, et al.
Publicado: (2008)

Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine
por: Rudenko, Larisa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6eehbresdjvqb0vmbda7i0d5cl